New Orlean BioInnovation Center

Mission

We’re a nonprofit business incubator dedicated to fostering entrepreneurship and supporting Louisiana innovators as they develop life-saving new technologies.

Tenants and clients supported by our program teams include startups developing innovative new medical devices, therapeutics, diagnostics, digital health platforms, clean technologies, and more. These technologies range from cancer and diabetes treatments to urban farming and water remediation solutions. All promise to improve global health.

 

Community

Part of Louisiana’s commitment to nurturing biotechnology, the Center stimulates bioscience entrepreneurship in Louisiana. With numerous research facilities and a growing life science economy, Greater New Orleans offers key elements necessary to launch a life science venture, and we assist over 100 new companies in commercializing technologies within the region.

The facility is housed in downtown’s burgeoning medical district, where more than $2.3 billion has been invested in new hospital and medical research construction. We work with independent innovators and researchers from major institutions including Tulane, LSU Health, Xavier and UNO.

Programs

To help realize ideas that will improve the quality of life for millions, we offer:

The Commercialization team offers various types of business assistance. Assistance services including business planning, intellectual property and market analyses, support in accessing various capital sources, and connecting entrepreneurs to external resources and key industry players. In addition, the team offers year-round educational workshops on various business topics.

Futhermore, NOBIC also runs the New Orleans BioFund. This innovative program that offers various capital options to these startups who are unable to access capital elsewhere. These investments help bridge a critical funding gap, thus allowing companies to better position themselves for more traditional funding opportunities in the future. The BioFund currently offers both debt and equity capital vehicles.